Results 141 to 150 of about 15,125 (212)

Enthesitis-Related Arthritis [PDF]

, 2020
openaire   +1 more source

Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry. [PDF]

Clin Rheumatol
Ata EB, Kılıç L, Fırlatan Yazgan B, Kart Bayram SG, Ekici M, Ünaldı E, Kuştaş AA, Bulat B, Karadağ Ö, Akdoğan A, Apraş Bilgen Ş, Kiraz S, Ertenli İ, Bilginer Y, Özen S, Kalyoncu U.   +15 more
europepmc   +1 more source

Psoriatic arthritis management: a comparative analysis of PANLAR, EULAR, and GRAPPA treatment recommendations. [PDF]

Ther Adv Musculoskelet Dis
Bautista-Molano W, Fernández-Ávila DG, Soriano ER.   +2 more
europepmc   +1 more source

Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database. [PDF]

Clin Rheumatol
Bodur H, Ataman Ş, Yurdakul FG, Gürer G, Akgün K, İnceoğlu LA, Sunar İ, Akgül Ö, Sezer İ, Çapkın E, Rezvani A, Yağcı İ, Duruöz MT, Çay HF, Çevik R, Göğüş F, Kamanlı A, Ecesoy H, Güler T, Şahin N, Cengiz G, Melikoğlu MA.   +21 more
europepmc   +1 more source

Year in Review: Axial Spondyloarthritis. [PDF]

Mediterr J Rheumatol
Katsifis-Nezis D, Fanouriakis A.
europepmc   +1 more source

Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials. [PDF]

Arthritis Res Ther
Gossec L, Balanescu A, D'Agostino MA, Ogdie A, Sewerin P, Deng Y, Shi L, Sugimoto Y, Zhong S, Xing Y, Lippe R, Kishimoto M.   +11 more
europepmc   +1 more source

Periodontal Status and Disease Activity in Psoriatic Arthritis and Psoriasis: A Cross-Sectional Study. [PDF]

Arch Rheumatol
Akyuz B, Durmus H, Baytımur H, Tomay Aksoy O, Basak G, Daltaban O, Alpsoy E, Sezer İ, Kacar C.   +8 more
europepmc   +1 more source

Subclinical Spondyloarthritis Features in Patients with Hidradenitis Suppurativa: A Real-World Cross-Sectional Analysis. [PDF]

J Clin Pract Res
Bakay U, Bakay ÖSK.
europepmc   +1 more source

The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis. [PDF]

Mediterr J Rheumatol
Katsouli O, Lainis V, Goules AV, Vlachoyiannopoulos PG.   +3 more
europepmc   +1 more source

Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study. [PDF]

RMD Open
Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F.   +13 more
europepmc   +1 more source